Eli Lilly, Sanford-Burnham Medical Research Institute Partner To Develop New Disease Therapies
The Sanford-Burnham Medical Research Institute in La Jolla has announced a new partnership with Eli Lilly and Company to find new therapies for diseases, including inflammatory bowel disease and lupus. Thomas Bumol, senior vice president of biotechnology and immunology research at Eli Lilly, and Carl Ware, director of Sanford-Burnham's Infectious and Inflammatory Diseases Center, will lead the partnership.
- "Sanford-Burnham and Eli Lilly Ally" (Fikes, U-T San Diego, 5/17).